Lactate activates the mitochondrial electron transport chain independently of its metabolism.
TCA cycle
electron transport chain
glycolysis
lactate
mitochondria
oxidative phosphorylation
Journal
Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571
Informations de publication
Date de publication:
02 Nov 2023
02 Nov 2023
Historique:
received:
30
05
2023
revised:
02
08
2023
accepted:
28
09
2023
medline:
6
11
2023
pubmed:
26
10
2023
entrez:
25
10
2023
Statut:
ppublish
Résumé
Lactate has long been considered a cellular waste product. However, we found that as extracellular lactate accumulates, it also enters the mitochondrial matrix and stimulates mitochondrial electron transport chain (ETC) activity. The resulting increase in mitochondrial ATP synthesis suppresses glycolysis and increases the utilization of pyruvate and/or alternative respiratory substrates. The ability of lactate to increase oxidative phosphorylation does not depend on its metabolism. Both L- and D-lactate are effective at enhancing ETC activity and suppressing glycolysis. Furthermore, the selective induction of mitochondrial oxidative phosphorylation by unmetabolized D-lactate reversibly suppressed aerobic glycolysis in both cancer cell lines and proliferating primary cells in an ATP-dependent manner and enabled cell growth on respiratory-dependent bioenergetic substrates. In primary T cells, D-lactate enhanced cell proliferation and effector function. Together, these findings demonstrate that lactate is a critical regulator of the ability of mitochondrial oxidative phosphorylation to suppress glucose fermentation.
Identifiants
pubmed: 37879334
pii: S1097-2765(23)00800-6
doi: 10.1016/j.molcel.2023.09.034
pii:
doi:
Substances chimiques
Lactic Acid
33X04XA5AT
Adenosine Triphosphate
8L70Q75FXE
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3904-3920.e7Commentaires et corrections
Type : UpdateOf
Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests C.B.T. is a founder of Agios Pharmaceuticals and is on the Board of Directors of Regeneron and Charles River Laboratories.